Neway Partners with Quest Diagnostics to Revolutionize Dialysis Laboratory Testing
Neway, LLC, the leading provider of value-based dialysis lab care in the United States, has announced a strategic lab services arrangement with Quest Diagnostics. This collaboration aims to enhance dialysis laboratory testing and reduce costs for patients with end-stage renal disease (ESRD).
Under the agreement, Neway will leverage Quest Diagnostics’ extensive lab network to offer local dialysis laboratory testing services with rapid turnaround times. Patients can expect to receive their test results within a day after arrival at a Quest Diagnostics laboratory. This innovative approach eliminates the need for transporting specimens to a centralized lab, which can be time-consuming and expensive.
Bryan Thompson, the Founder and CEO of Neway, expressed his enthusiasm for this partnership, stating, “The Neway solution exemplifies our dedication to bringing value, innovation, stewardship, and economies of scale to the unique dialysis industry. The ‘new way’ for dialysis laboratory testing is a decentralized network of laboratory locations that spans the nation. This approach is good for dialysis patients, dialysis programs, insurance payers, and the entire dialysis industry. It is a win for everyone.”
Quest Diagnostics, a leader in cardiometabolic diagnostic solutions, understands the challenges faced by patients with ESRD and the importance of rapid testing without compromising quality. Mouris Saghir, PhD, Vice President and General Manager for the Quest Diagnostics National Cardiometabolic Center of Excellence at Cleveland HeartLab, emphasized the commitment to expedite test results while maintaining the highest level of quality for ESRD patients.
By leveraging Quest Diagnostics’ distributed network of labs, Neway and its affiliated dialysis centers will provide faster testing and results reporting, ultimately improving patient care and reducing transportation costs.
This strategic collaboration between Neway and Quest Diagnostics marks a significant milestone in the dialysis industry, bringing much-needed innovation to laboratory testing. With a focus on value, efficiency, and patient outcomes, this partnership sets a new standard for dialysis laboratory services.
For more information about this partnership, please visit the original press release [link to press release].
About Neway, LLC:
Neway, LLC is a leading provider of value-based dialysis lab care in the United States. With a commitment to innovation and improving patient outcomes, Neway aims to revolutionize the dialysis industry through its strategic partnerships and decentralized laboratory testing approach.
About Quest Diagnostics:
Quest Diagnostics is a renowned provider of diagnostic information services, specializing in cardiometabolic diagnostics, including kidney disease. With a focus on quality and rapid testing, Quest Diagnostics plays a crucial role in supporting healthcare providers and patients in making informed decisions about their health.